Details for Patent: 8,461,333
✉ Email this page to a colleague
Which drugs does patent 8,461,333 protect, and when does it expire?
Patent 8,461,333 protects RUKOBIA and is included in one NDA.
This patent has thirty-nine patent family members in thirty countries.
Summary for Patent: 8,461,333
| Title: | Salts of prodrugs of piperazine and substituted piperidine antiviral agents |
| Abstract: | This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. ##STR00001## wherein: X is C or N with the proviso that when X is N, R.sup.1 does not exist; W is C or N with the proviso that when W is N, R.sup.2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of ##STR00002## Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. ##STR00003## wherein: L and M are independently selected from the group consisting of C.sub.1-C.sub.6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy. |
| Inventor(s): | Ueda; Yasutsugu (Clinton, CT), Connolly; Timothy P. (Portland, CT), Kadow; John F. (Wallingford, CT), Meanwell; Nicholas A. (East Hampton, CT), Wang; Tao (Farmington, CT), Chen; Chung-Pin H. (Madison, CT), Yeung; Kap-Sun (Madison, CT), Zhang; Zhongxing (Madison, CT), Leahy; David Kenneth (Hightstown, NJ), Pack; Shawn K. (Plainsboro, NJ), Soundararajan; Nachimuthu (Kendall Park, NJ), Sirard; Pierre (St. Jean sur Richelieu, CA), Levesque; Kathia (Ste-Catherine, CA), Thoraval; Dominique (Candiac, CA) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 13/429,838 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,461,333
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | RUKOBIA | fostemsavir tromethamine | TABLET, EXTENDED RELEASE;ORAL | 212950-001 | Jul 2, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,461,333
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 048039 | ⤷ Try a Trial | |||
| Austria | E384728 | ⤷ Try a Trial | |||
| Australia | 2005223736 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
